The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Incidence of Death and Acute Myocardial Infarction Associated With Stopping Clopidogrel After Acute Coronary Syndrome
Abstract
CONTEXT: It is unknown whether patients are at increased short-term risk for adverse events following clopidogrel cessation. OBJECTIVE: To assess the rates of adverse events after stopping treatment with clopidogrel in a national sample of patients with acute coronary syndrome (ACS). DESIGN, SETTING, AND PATIENTS: Retrospective cohort study of 3137 patients with ACS discharged from 127 Veterans Affairs hospitals between October 1, 2003, and March 31, 2005, with posthospital treatment with clopidogrel. MAIN OUTCOME MEASURE: Rate of all-cause mortality or acute myocardial infarction (AMI) after stopping treatment with clopidogrel. RESULTS: Mean (SD) follow-up after stopping treatment with clopidogrel was 196 (152) days for medically treated patients with ACS without stents (n = 1568) and 203 (148) days for patients with ACS treated with percutaneous coronary intervention (PCI) (n = 1569). Among medically treated patients, mean (SD) duration of clopidogrel treatment was 278 [corrected] (169) [corrected] days and death or AMI occurred in 17.1% (n = 268) of patients, with 60.8% (n = 163) of events occurring during 0 to 90 days, 21.3% (n = 57) during 91 to 180 days, and 9.7% (n = 26) during 181 to 270 days after stopping treatment with clopidogrel. In multivariable analysis including adjustment for duration of clopidogrel treatment, the first 90-day interval after stopping treatment with clopidogrel was associated with a significantly higher risk of adverse events (incidence rate ratio [IRR], 1.98; 95% confidence interval [CI], 1.46-2.69 vs the interval of 91-180 days). Similarly, among PCI-treated patients with ACS, mean (SD) duration of clopidogrel treatment was 302 [corrected] (151) [corrected] days and death or AMI occurred in 7.9% (n = 124) of patients, with 58.9% (n = 73) of events occurring during 0 to 90 days, 23.4% (n = 29) during 91 to 180 days, and 6.5% (n = 8) during 181 to 270 days after stopping clopidogrel treatment. In multivariable analysis including adjustment for duration of clopidogrel treatment, the first 90-day interval after stopping clopidogrel treatment was associated with a significantly higher risk of adverse events (IRR, 1.82; 95% CI, 1.17-2.83). CONCLUSIONS: We observed a clustering of adverse events in the initial 90 days after stopping clopidogrel among both medically treated and PCI-treated patients with ACS, supporting the possibility of a clopidogrel rebound effect. Additional studies are needed to confirm the clustering of events after stopping clopidogrel, including associations with cardiovascular mortality and reasons for stopping clopidogrel, as well as to determine the mechanism of this phenomenon, and to identify strategies to reduce early events after clopidogrel cessation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470 · cited 2×
“The average duration of clopidogrel treatment in the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) trial was 9 months following hospital discharge.(1) Current cardiology guidelines recommend clopidogrel therapy for at least 1 month and ideally up to 1 year for patients treated medically or with a b…”
MethodBraunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,487
Steinhubl, S. R., Berger, P. B., Mann III, J. T., Fry, E. T. A., DeLago, A., Wilmer, C., Topol, E. J., & for the CREDO Investigators (2002) · JAMA · doi:10.1001/jama.288.19.2411 · Cited by 3,078
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060989 · Cited by 2,837
Mehta, S. R., Yusuf, S., & Peters, R. J. G. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00559-7 · Cited by 2,578
Diener, H.-C., Bogousslavsky, J., Brass, L. M., Cimminiello, C., Csiba, L., Kaste, M., Leys, D., Matias-Guiu, J., & Rupprecht, H.-J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16721-4 · Cited by 2,275
Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1836 · Cited by 1,135
Self-citationBURGER, W., CHEMNITIUS, J. ‐., KNEISSL, G. D., & RÜCKER, G. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01477.x · Cited by 891
Biondi-Zoccai, G. G. L., Lotrionte, M., Agostoni, P., Abbate, A., Fusaro, M., Burzotta, F., Testa, L., Sheiban, I., & Sangiorgi, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl334 · Cited by 733
Accuracy and completeness of mortality data in the Department of Veterans Affairs
Sohn, M.-W., Arnold, N., Maynard, C., & Hynes, D. M. (2006) · Population Health Metrics · doi:10.1186/1478-7954-4-2 · Cited by 542
A Primer and Comparative Review of Major U.S. Mortality Databases
Cowper, D. C., Kubal, J. D., Maynard, C., & Hynes, D. M. (2002) · Annals of Epidemiology · doi:10.1016/s1047-2797(01)00285-x · Cited by 486
Reactivation of Unstable Angina after the Discontinuation of Heparin
Théroux, P., Waters, D., Lam, J., Juneau, M., & McCans, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207163270301 · Cited by 464
Steiner, J. F., Koepsell, T. D., Fihn, S. D., & Inui, T. S. (1988) · Medical Care · doi:10.1097/00005650-198808000-00007 · Cited by 458
Coronary syndromes following aspirin withdrawal
Ferrari, E., Benhamou, M., Cerboni, P., & Marcel, B. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.041 · Cited by 389
Xiao, Z., & Théroux, P. (1998) · Circulation · doi:10.1161/01.cir.97.3.251 · Cited by 382
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes
Collet, J. P., Montalescot, G., Blanchet, B., Tanguy, M. L., Golmard, J. L., Choussat, R., Beygui, F., Payot, L., Vignolles, N., Metzger, J. P., et al. (2004) · Circulation · doi:10.1161/01.cir.0000145171.89690.b4 · Cited by 372
Effect of Discontinuing Aspirin Therapy on the Risk of Brain Ischemic Stroke
Maulaz, A. B., Bezerra, D. C., Michel, P., & Bogousslavsky, J. (2005) · Archives of Neurology · doi:10.1001/archneur.62.8.1217 · Cited by 310
Petersen, L. A., Wright, S., Normand, S.-L. T., & Daley, J. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.10198.x · Cited by 233
Granger, C. B., Miller, J. M., Bovill, E. G., Gruber, A., Tracy, R. P., Krucoff, M. W., Green, C., Berrios, E., Harrington, R. A., Ohman, E. M., et al. (1995) · Circulation · doi:10.1161/01.cir.91.7.1929 · Cited by 197
Caetano, P. A., Lam, J. M. C., & Morgan, S. G. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.09.021 · Cited by 159
Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Ramírez, C., Sabaté, M., Jimenez-Quevedo, P., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1394 · Cited by 158
Transition to the new race/ethnicity data collection standards in the Department of Veterans Affairs
Sohn, M., Zhang, H.-Y., Arnold, N., Stroupe, K. T., Taylor, B. C., Wilt, T., & Hynes, D. (2006) · Population Health Metrics · doi:10.1186/1478-7954-4-7 · Cited by 103
Grines, C. L., Bonow, R. O., Casey, D. E., Gardner, T. J., Lockhart, P. B., Moliterno, D. J., O’Gara, P. T., & Whitlow, P. L. (2007) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2007.0237 · Cited by 99
Valgimigli, M., Campo, G. C., Arcozzi, C., Malagutti, P., Carletti, R., Ferrari, F., Barbieri, D., Parrinello, G., Percoco, G., & Ferrari, R. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.029 · Cited by 81
Maynard, C. C., Lowy, E., Rumsfeld, J. S., Sales, A., Sun, H., Kopjar, B., Fleming, B. B., Jesse, R. L., Rusch, R., & Fihn, S. D. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1410 · Cited by 57
Serebruany, V. L., Malinin, A. I., & Bhatt, D. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.11.007 · Cited by 50
Serebruany, V. L., Midei, M. G., Meilman, H., Malinin, A., & Lowry, D. R. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.00999.x · Cited by 32
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
Authors/Task Force Members, Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr236 · Cited by 3,080
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O'Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.019 · Cited by 2,625
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Mauri, L., Kereiakes, D. J., Yeh, R. W., Driscoll-Shempp, P., Cutlip, D. E., Steg, P. G., Normand, S.-L. T., Braunwald, E., Wiviott, S. D., Cohen, D. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409312 · Cited by 1,928
Metadata
- Authors
- Ho, P. M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-02-06
- Volume
- 299
- Issue
- 5
- Pages
- 532
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2111622726
- Cited by
- 391
- References
- 28
- FWCI
- 39.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.